🌍 EC REP & Economic operators

MDR Distributor: New Obligations, Verifications and Traceability

Checking the CE marking, the language of the instructions and UDI registration conditions any making available. Traceability runs for 5 years, 10 for implantables, and co-branding shifts the distributor into manufacturer status.

8 min read

The distributor is defined by Article 2(34) of the MDR as any natural or legal person in the supply chain, other than the manufacturer or the importer, that makes a device available on the market up until the point of putting into service. Article 14 of the MDR imposes far more precise obligations on the distributor than those provided for under Directive 93/42/EEC.

Mandatory verifications before making the device available

Before making a device available, the distributor must verify that the device bears CE marking and is accompanied by the EU declaration of conformity. The distributor must verify that the labelling and the IFU are in the official language of the Member State in which the device is made available. The distributor must verify that the manufacturer and the importer have fulfilled their registration obligations (UDI, EUDAMED).

If the distributor finds that the device is not in conformity, it cannot make it available. The distributor must inform the manufacturer, the importer and, where a non-conformity presents a risk, the competent authority.

Traceability obligations

The distributor must keep the information that makes it possible to identify the manufacturer, the importer, the devices supplied, and the professional purchasers downstream in the chain. This traceability must be maintained for 5 years (10 years for implantable devices).

In practice, this means a register of purchases and sales by reference and by batch, kept for the required period.

The risk of being reclassified as a manufacturer

This is the point that many distributors overlook, with potentially serious consequences. If a distributor modifies a device in a way that may affect its conformity, repackages a sterile device by altering its primary packaging, or affixes its own trademark to a device without mentioning the name of the original manufacturer, it is considered a manufacturer within the meaning of the MDR.

This reclassification entails all of the manufacturer’s obligations: technical documentation, declaration of conformity, CE marking, QMS, PMS, vigilance, PRRC. Some distributors find themselves in this situation without having anticipated it, particularly those engaged in co-branding or repackaging.

Regulatory source: Article 14 of Regulation (EU) 2017/745 — EUR-Lex

Topics covered:

MDR distributor MDR Article 14 medical device distributor obligations